{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:35:24Z","timestamp":1792362924293,"version":"4.4.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Else-Kr\u00f6ner-Fresenius Stiftung","award":["2023_EKEA.168"],"award-info":[{"award-number":["2023_EKEA.168"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease is increasingly recognized as a heterogeneous syndrome characterized by diverse pathological processes and clinical manifestations. Here, we propose a multidimensional framework to assess this heterogeneity, with each dimension potentially captured using advanced magnetic resonance imaging techniques. The framework comprises dominant pathological processes, spatial distribution patterns of pathology across brain regions, propagation architecture, temporal dynamics of disease progression, co-pathology burden, and system response and resilience mechanisms.<\/jats:p>","DOI":"10.1038\/s41531-026-01544-z","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:06:33Z","timestamp":1787846793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biological heterogeneity in Parkinson\u2019s disease: implications for MRI-based patient stratification"],"prefix":"10.1038","volume":"12","author":[{"given":"Marta M.","family":"Pokotylo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Prasuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"1544_CR1","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1093\/brain\/awae303","volume":"147","author":"Y Sakato","year":"2024","unstructured":"Sakato, Y. et al. Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson\u2019s disease. Brain 147, 3702\u20133713 (2024).","journal-title":"Brain"},{"key":"1544_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/02841851241297207","volume":"66","author":"S Zang","year":"2025","unstructured":"Zang, S., Pan, Y., Chen, M. & Zhang, G. Different iron distribution patterns in Parkinson\u2019s disease and its motor subtypes: a quantitative susceptibility mapping study. Acta Radiol. 66, 99\u2013106 (2025).","journal-title":"Acta Radiol."},{"key":"1544_CR3","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.21037\/qims-20-285","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Different iron deposition patterns in Parkinson\u2019s disease subtypes: a quantitative susceptibility mapping study. Quant. Imaging Med. Surg. 10, 2168\u20132176 (2020).","journal-title":"Quant. Imaging Med. Surg."},{"key":"1544_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","volume":"130","author":"U W\u00fcllner","year":"2023","unstructured":"W\u00fcllner, U. et al. The heterogeneity of Parkinson\u2019s disease. J. Neural Transm. 130, 827\u2013838 (2023).","journal-title":"J. Neural Transm."},{"key":"1544_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41531-023-00503-2","volume":"9","author":"M Mart\u00ednez","year":"2023","unstructured":"Mart\u00ednez, M. et al. Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson\u2019s disease. Npj Park. Dis. 9, 62 (2023).","journal-title":"Npj Park. Dis."},{"key":"1544_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-020-00144-9","volume":"7","author":"RD Markello","year":"2021","unstructured":"Markello, R. D. et al. Multimodal phenotypic axes of Parkinson\u2019s disease. Npj Park. Dis. 7, 6 (2021).","journal-title":"Npj Park. Dis."},{"key":"1544_CR7","first-page":"S297","volume":"14","author":"M Hu","year":"2024","unstructured":"Hu, M., Skj\u00e6rb\u00e6k, C. & Borghammer, P. Approaches to early Parkinson\u2019s disease subtyping. J. Park. Dis. 14, S297\u2013S306 (2024).","journal-title":"J. Park. Dis."},{"key":"1544_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/jmri.70110","volume":"63","author":"X Liu","year":"2026","unstructured":"Liu, X. et al. Hemispheric asymmetry of neuromelanin-iron dysfunction in the substantia nigra: MRI-based evidence for lateralized motor onset in early-stage Parkinson\u2019s disease. J. Magn. Reson. Imaging 63, 196\u2013204 (2026).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1544_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali, A., Thomas, G. E. C., Zetterberg, H. & Weil, R. S. Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat. Commun. 15, 5661 (2024).","journal-title":"Nat. Commun."},{"key":"1544_CR10","doi-asserted-by":"publisher","first-page":"102603","DOI":"10.1016\/j.pneurobio.2024.102603","volume":"236","author":"KE Stige","year":"2024","unstructured":"Stige, K. E. et al. The STRAT-PARK cohort: a personalized initiative to stratify Parkinson\u2019s disease. Prog. Neurobiol. 236, 102603 (2024).","journal-title":"Prog. Neurobiol."},{"key":"1544_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41531-022-00405-9","volume":"8","author":"D Ben Bashat","year":"2022","unstructured":"Ben Bashat, D. et al. Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson\u2019s disease. Npj Park. Dis. 8, 139 (2022).","journal-title":"Npj Park. Dis."},{"key":"1544_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-023-00461-9","volume":"9","author":"S Kaiser","year":"2023","unstructured":"Kaiser, S. et al. A proteogenomic view of Parkinson\u2019s disease causality and heterogeneity. Npj Park. Dis. 9, 24 (2023).","journal-title":"Npj Park. Dis."},{"key":"1544_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-024-00730-1","volume":"10","author":"Z Xu","year":"2024","unstructured":"Xu, Z. et al. Disease progression in proposed brain-first and body-first Parkinson\u2019s disease subtypes. Npj Park. Dis. 10, 111 (2024).","journal-title":"Npj Park. Dis."},{"key":"1544_CR14","doi-asserted-by":"publisher","first-page":"105599","DOI":"10.1016\/j.nbd.2021.105599","volume":"163","author":"N Van Den Berge","year":"2022","unstructured":"Van Den Berge, N. & Ulusoy, A. Animal models of brain-first and body-first Parkinson\u2019s disease. Neurobiol. Dis. 163, 105599 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1544_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger, G. U. et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 23, 191\u2013204 (2024).","journal-title":"Lancet Neurol."},{"key":"1544_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"1544_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neulet.2016.12.036","volume":"638","author":"Y Xiang","year":"2017","unstructured":"Xiang, Y. et al. Subtypes evaluation of motor dysfunction in Parkinson\u2019s disease using neuromelanin-sensitive magnetic resonance imaging. Neurosci. Lett. 638, 145\u2013150 (2017).","journal-title":"Neurosci. Lett."},{"key":"1544_CR18","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell, T. et al. Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review. JAMA Neurol. 78, 1262 (2021).","journal-title":"JAMA Neurol."},{"key":"1544_CR19","doi-asserted-by":"publisher","first-page":"121012","DOI":"10.1016\/j.neuroimage.2025.121012","volume":"306","author":"L Hua","year":"2025","unstructured":"Hua, L., Huang, C., Zeng, X., Gao, F. & Yuan, Z. Individualized brain radiomics-based network tracks distinct subtypes and abnormal patterns in prodromal Parkinson\u2019s disease. NeuroImage 306, 121012 (2025).","journal-title":"NeuroImage"},{"key":"1544_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/brainsci11060769","volume":"11","author":"P Feraco","year":"2021","unstructured":"Feraco, P. et al. Imaging of substantia nigra in Parkinson\u2019s disease: a narrative review. Brain Sci. 11, 769 (2021).","journal-title":"Brain Sci."},{"key":"1544_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3389\/fneur.2020.00791","volume":"11","author":"G Arribarat","year":"2020","unstructured":"Arribarat, G., De Barros, A. & P\u00e9ran, P. Modern brainstem MRI techniques for the diagnosis of Parkinson\u2019s disease and parkinsonisms. Front. Neurol. 11, 791 (2020).","journal-title":"Front. Neurol."},{"key":"1544_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0964-5","volume":"19","author":"S Prange","year":"2019","unstructured":"Prange, S., Metereau, E. & Thobois, S. Structural imaging in Parkinson\u2019s disease: new developments. Curr. Neurol. Neurosci. Rep. 19, 50 (2019).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1544_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/ctn7010008","volume":"7","author":"DH Benninger","year":"2023","unstructured":"Benninger, D. H. et al. Clinical phenotype imprints on brain atrophy progression in Parkinson\u2019s disease. Clin. Transl. Neurosci. 7, 8 (2023).","journal-title":"Clin. Transl. Neurosci."},{"key":"1544_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202511289","volume":"12","author":"X Duanmu","year":"2025","unstructured":"Duanmu, X. et al. MRI epicenters differentiate spatiotemporal patterns of neurodegeneration in Parkinson\u2019s disease. Adv. Sci. 12, e11289 (2025).","journal-title":"Adv. Sci."},{"key":"1544_CR25","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1093\/brain\/awab191","volume":"144","author":"E Biondetti","year":"2021","unstructured":"Biondetti, E. et al. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson\u2019s disease. Brain 144, 3114\u20133125 (2021).","journal-title":"Brain"},{"key":"1544_CR26","doi-asserted-by":"publisher","unstructured":"Park, G., Ha, J., Youn, J. & Kim, H. Data-driven MRI-based subtyping of Parkinson\u2019s disease reveals cortex-first and deep grey-first progression patterns. 4554, https:\/\/doi.org\/10.58530\/2025\/4554 (2025).","DOI":"10.58530\/2025\/4554"},{"key":"1544_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01481","volume":"5","author":"VR Mishra","year":"2019","unstructured":"Mishra, V. R. et al. Influence of analytic techniques on comparing DTI-derived measurements in early stage Parkinson\u2019s disease. Heliyon 5, e01481 (2019).","journal-title":"Heliyon"},{"key":"1544_CR28","doi-asserted-by":"publisher","unstructured":"Oh, Y., Park, G. & Kim, H. Data driven subtyping reveals two distinctive patterns of deep gray matter atrophy and dopamine availability in early Parkinson\u2019s disease. 4539, https:\/\/doi.org\/10.58530\/2025\/4539 (2025).","DOI":"10.58530\/2025\/4539"},{"key":"1544_CR29","doi-asserted-by":"publisher","first-page":"1439443","DOI":"10.3389\/fnins.2024.1439443","volume":"18","author":"X Yuan","year":"2024","unstructured":"Yuan, X. et al. Microstructural alterations in white matter and related neurobiology based on the new clinical subtypes of Parkinson\u2019s disease. Front. Neurosci. 18, 1439443 (2024).","journal-title":"Front. Neurosci."},{"key":"1544_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/mdc3.13107","volume":"8","author":"JT Boonstra","year":"2021","unstructured":"Boonstra, J. T., Michielse, S., Temel, Y., Hoogland, G. & Jahanshahi, A. Neuroimaging detectable differences between Parkinson\u2019s disease motor subtypes: a systematic review. Mov. Disord. Clin. Pract. 8, 175\u2013192 (2021).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1544_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00702-020-02295-8","volume":"128","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease. J. Neural Transm. 128, 171\u2013179 (2021).","journal-title":"J. Neural Transm."},{"key":"1544_CR32","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.parkreldis.2025.107933","volume":"137","author":"X Shao","year":"2025","unstructured":"Shao, X. et al. Regional neuromelanin reduction in the substantia nigra in different subtype of Parkinson\u2019s disease. Parkinsonism Relat. Disord. 137, 107933 (2025).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1544_CR33","doi-asserted-by":"publisher","first-page":"106181","DOI":"10.1016\/j.clineuro.2020.106181","volume":"198","author":"W Xiong","year":"2020","unstructured":"Xiong, W. et al. Different iron deposition patterns in akinetic\/rigid-dominant and tremor-dominant Parkinson\u2019s disease. Clin. Neurol. Neurosurg. 198, 106181 (2020).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1544_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41531-021-00199-2","volume":"7","author":"F Depierreux","year":"2021","unstructured":"Depierreux, F. et al. Parkinson\u2019s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. Npj Park. Dis. 7, 57 (2021).","journal-title":"Npj Park. Dis."},{"key":"1544_CR35","doi-asserted-by":"publisher","first-page":"137249","DOI":"10.1016\/j.neulet.2023.137249","volume":"807","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson\u2019s disease. Neurosci. Lett. 807, 137249 (2023).","journal-title":"Neurosci. Lett."},{"key":"1544_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnagi.2019.00106","volume":"11","author":"K Ghassaban","year":"2019","unstructured":"Ghassaban, K. et al. Regional high iron in the substantia nigra differentiates Parkinson\u2019s disease patients from healthy controls. Front. Aging Neurosci. 11, 106 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"1544_CR37","doi-asserted-by":"publisher","first-page":"e102417","DOI":"10.1136\/bmjopen-2025-102417","volume":"15","author":"R Yang","year":"2025","unstructured":"Yang, R. et al. PANDA study: subtyping of Parkinson\u2019s disease \u2013 cohort study protocol. BMJ Open 15, e102417 (2025).","journal-title":"BMJ Open"},{"key":"1544_CR38","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1080\/14656566.2023.2242786","volume":"24","author":"P Tall","year":"2023","unstructured":"Tall, P. et al. The Park Sleep subtype in Parkinson\u2019s disease: from concept to clinic. Expert Opin. Pharmacother. 24, 1725\u20131736 (2023).","journal-title":"Expert Opin. Pharmacother."},{"key":"1544_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fneur.2020.00395","volume":"11","author":"E Hustad","year":"2020","unstructured":"Hustad, E. & Aasly, J. O. Clinical and imaging markers of prodromal Parkinson\u2019s disease. Front. Neurol. 11, 395 (2020).","journal-title":"Front. Neurol."},{"key":"1544_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.trsl.2015.12.006","volume":"175","author":"P Tuite","year":"2016","unstructured":"Tuite, P. Magnetic resonance imaging as a potential biomarker for Parkinson\u2019s disease. Transl. Res. 175, 4\u201316 (2016).","journal-title":"Transl. Res."},{"key":"1544_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/diagnostics12030637","volume":"12","author":"YS Kim","year":"2022","unstructured":"Kim, Y. S., Lee, J.-H. & Gahm, J. K. Automated differentiation of atypical parkinsonian syndromes using brain iron patterns in susceptibility weighted imaging. Diagnostics 12, 637 (2022).","journal-title":"Diagnostics"},{"key":"1544_CR42","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1111\/ejn.16296","volume":"59","author":"Y Yan","year":"2024","unstructured":"Yan, Y., Zhang, M., Ren, W., Zheng, X. & Chang, Y. Neuromelanin-sensitive magnetic resonance imaging: possibilities and promises as an imaging biomarker for Parkinson\u2019s disease. Eur. J. Neurosci. 59, 2616\u20132627 (2024).","journal-title":"Eur. J. Neurosci."},{"key":"1544_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mds.27608","volume":"34","author":"J Langley","year":"2019","unstructured":"Langley, J. et al. Reproducible detection of nigral iron deposition in 2 Parkinson\u2019s disease cohorts. Mov. Disord. 34, 416\u2013419 (2019).","journal-title":"Mov. Disord."},{"key":"1544_CR44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fneur.2020.00366","volume":"11","author":"N Pyatigorskaya","year":"2020","unstructured":"Pyatigorskaya, N. et al. Iron imaging as a diagnostic tool for Parkinson\u2019s disease: a systematic review and meta-analysis. Front. Neurol. 11, 366 (2020).","journal-title":"Front. Neurol."},{"key":"1544_CR45","doi-asserted-by":"publisher","first-page":"1287917","DOI":"10.3389\/fnagi.2023.1287917","volume":"15","author":"S Hartono","year":"2023","unstructured":"Hartono, S. et al. Quantitative iron\u2013neuromelanin MRI associates with motor severity in Parkinson\u2019s disease and matches radiological disease classification. Front. Aging Neurosci. 15, 1287917 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1544_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/mdc3.12590","volume":"5","author":"N Pavese","year":"2018","unstructured":"Pavese, N. & Tai, Y. F. Nigrosome imaging and neuromelanin sensitive MRI in diagnostic evaluation of parkinsonism. Mov. Disord. Clin. Pract. 5, 131\u2013140 (2018).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1544_CR47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.4103\/aian.aian_285_22","volume":"25","author":"D Biswas","year":"2022","unstructured":"Biswas, D. et al. Nigrosome and neuromelanin imaging as tools to differentiate Parkinson\u2019s disease and parkinsonism. Ann. Indian Acad. Neurol. 25, 1029\u20131035 (2022).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"1544_CR48","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/aww022","volume":"139","author":"DJ Hare","year":"2016","unstructured":"Hare, D. J. & Double, K. L. Iron and dopamine: a toxic couple. Brain 139, 1026\u20131035 (2016).","journal-title":"Brain"},{"key":"1544_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01874-2","volume":"20","author":"AF Wolters","year":"2020","unstructured":"Wolters, A. F. et al. The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson\u2019s disease. BMC Neurol. 20, 292 (2020).","journal-title":"BMC Neurol."},{"key":"1544_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16546","volume":"32","author":"J Wen","year":"2025","unstructured":"Wen, J. et al. Spatiotemporal neurodegeneration of the substantia nigra and its connecting cortex and subcortex in Parkinson\u2019s disease. Eur. J. Neurol. 32, e16546 (2025).","journal-title":"Eur. J. Neurol."},{"key":"1544_CR51","doi-asserted-by":"publisher","first-page":"13678","DOI":"10.3390\/ijms232213678","volume":"23","author":"BM Pizarro-Galleguillos","year":"2022","unstructured":"Pizarro-Galleguillos, B. M., Kunert, L., Br\u00fcggemann, N. & Prasuhn, J. Iron- and neuromelanin-weighted neuroimaging to study mitochondrial dysfunction in patients with Parkinson\u2019s disease. Int. J. Mol. Sci. 23, 13678 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1544_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jmri.28414","volume":"57","author":"N He","year":"2023","unstructured":"He, N., Chen, Y., LeWitt, P. A., Yan, F. & Haacke, E. M. Application of neuromelanin MR imaging in Parkinson disease. J. Magn. Reson. Imaging 57, 337\u2013352 (2023).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1544_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer, D. et al. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease. Npj Park. Dis. 4, 11 (2018).","journal-title":"Npj Park. Dis."},{"key":"1544_CR54","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1007\/s00415-021-10582-x","volume":"268","author":"SJ Cho","year":"2021","unstructured":"Cho, S. J. et al. Iron-sensitive magnetic resonance imaging in Parkinson\u2019s disease: a systematic review and meta-analysis. J. Neurol. 268, 4721\u20134736 (2021).","journal-title":"J. Neurol."},{"key":"1544_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-016-0064-2","volume":"5","author":"Z Wang","year":"2016","unstructured":"Wang, Z., Luo, X.-G. & Gao, C. Utility of susceptibility-weighted imaging in Parkinson\u2019s disease and atypical Parkinsonian disorders. Transl. Neurodegener. 5, 17 (2016).","journal-title":"Transl. Neurodegener."},{"key":"1544_CR56","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer, P. et al. Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson\u2019s disease. J. Neural Transm. 130, 627\u2013646 (2023).","journal-title":"J. Neural Transm."},{"key":"1544_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41531-022-00341-8","volume":"8","author":"K Steidel","year":"2022","unstructured":"Steidel, K. et al. Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson\u2019s disease. Npj Park. Dis. 8, 79 (2022).","journal-title":"Npj Park. Dis."},{"key":"1544_CR58","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mds.26968","volume":"32","author":"S Lehericy","year":"2017","unstructured":"Lehericy, S. et al. The role of high-field magnetic resonance imaging in parkinsonian disorders: pushing the boundaries forward. Mov. Disord. 32, 510\u2013525 (2017).","journal-title":"Mov. Disord."},{"key":"1544_CR59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/WCO.0000000000000584","volume":"31","author":"V Rispoli","year":"2018","unstructured":"Rispoli, V., Schreglmann, S. R. & Bhatia, K. P. Neuroimaging advances in Parkinson\u2019s disease. Curr. Opin. Neurol. 31, 415\u2013424 (2018).","journal-title":"Curr. Opin. Neurol."},{"key":"1544_CR60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/ijms25010498","volume":"25","author":"KA Jellinger","year":"2023","unstructured":"Jellinger, K. A. Pathobiology of cognitive impairment in Parkinson disease: challenges and outlooks. Int. J. Mol. Sci. 25, 498 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1544_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41582-025-01163-x","volume":"22","author":"P Oikonomou","year":"2026","unstructured":"Oikonomou, P., Akhoundi, F. H., Olfati, N. & Litvan, I. Characteristics and mechanisms of cognitive impairment in Parkinson disease. Nat. Rev. Neurol. 22, 90\u2013109 (2026).","journal-title":"Nat. Rev. Neurol."},{"key":"1544_CR62","doi-asserted-by":"publisher","first-page":"702502","DOI":"10.3389\/fneur.2021.702502","volume":"12","author":"LJ Dommershuijsen","year":"2021","unstructured":"Dommershuijsen, L. J., Boon, A. J. W. & Ikram, M. K. Probing the pre-diagnostic phase of Parkinson\u2019s disease in population-based studies. Front. Neurol. 12, 702502 (2021).","journal-title":"Front. Neurol."},{"key":"1544_CR63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s10020-021-00327-x","volume":"27","author":"SK Meles","year":"2021","unstructured":"Meles, S. K., Oertel, W. H. & Leenders, K. L. Circuit imaging biomarkers in preclinical and prodromal Parkinson\u2019s disease. Mol. Med. 27, 111 (2021).","journal-title":"Mol. Med."},{"key":"1544_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5114\/pjr\/213608","volume":"91","author":"JW Bocia\u0144ski","year":"2026","unstructured":"Bocia\u0144ski, J. W., Dorobek, M., Walecki, J., Mruk, B. & Sklinda, K. Magnetic resonance imaging in Parkinson\u2019s disease: from routine imaging to molecular biomarkers \u2013 an update for radiologists. Pol. J. Radiol. 91, 58\u201367 (2026).","journal-title":"Pol. J. Radiol."},{"key":"1544_CR65","doi-asserted-by":"publisher","first-page":"1518155","DOI":"10.3389\/fnagi.2024.1518155","volume":"16","author":"F Leng","year":"2025","unstructured":"Leng, F. et al. Iron deposition is associated with motor and non-motor network breakdown in parkinsonism. Front. Aging Neurosci. 16, 1518155 (2025).","journal-title":"Front. Aging Neurosci."},{"key":"1544_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41531-023-00519-8","volume":"9","author":"A Kuzkina","year":"2023","unstructured":"Kuzkina, A. et al. Combining skin and olfactory \u03b1-synuclein seed amplification assays (SAA)\u2014towards biomarker-driven phenotyping in synucleinopathies. Npj Park. Dis. 9, 79 (2023).","journal-title":"Npj Park. Dis."},{"key":"1544_CR67","doi-asserted-by":"publisher","first-page":"105310","DOI":"10.1016\/j.pdpdt.2025.105310","volume":"57","author":"F Nikparast","year":"2026","unstructured":"Nikparast, F. et al. OCT-based retinal biomarkers forecast central nervous system structural decline in Parkinson\u2019s disease: a longitudinal multimodal study within the Persian Cohort. Photodiagn. Photodyn. Ther. 57, 105310 (2026).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"1544_CR68","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1093\/brain\/awab142","volume":"144","author":"C O\u2019Callaghan","year":"2021","unstructured":"O\u2019Callaghan, C. et al. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson\u2019s disease. Brain 144, 2513\u20132526 (2021).","journal-title":"Brain"},{"key":"1544_CR69","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","volume":"31","author":"SJ Cho","year":"2021","unstructured":"Cho, S. J. et al. Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson\u2019s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis. Eur. Radiol. 31, 1268\u20131280 (2021).","journal-title":"Eur. Radiol."},{"key":"1544_CR70","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/jnc.15516","volume":"159","author":"NSR Bidesi","year":"2021","unstructured":"Bidesi, N. S. R., Vang Andersen, I., Windhorst, A. D., Shalgunov, V. & Herth, M. M. The role of neuroimaging in Parkinson\u2019s disease. J. Neurochem. 159, 660\u2013689 (2021).","journal-title":"J. Neurochem."},{"key":"1544_CR71","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/pharmaceutics15030770","volume":"15","author":"T Pardo-Moreno","year":"2023","unstructured":"Pardo-Moreno, T. et al. Current treatments and new, tentative therapies for Parkinson\u2019s disease. Pharmaceutics 15, 770 (2023).","journal-title":"Pharmaceutics"},{"key":"1544_CR72","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jmri.29073","volume":"60","author":"M Ariz","year":"2024","unstructured":"Ariz, M. et al. Automatic segmentation and quantification of nigrosome-1 neuromelanin and iron in MRI: a candidate biomarker for Parkinson\u2019s disease. J. Magn. Reson. Imaging 60, 534\u2013547 (2024).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1544_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fneur.2019.00074","volume":"10","author":"J-H Lee","year":"2019","unstructured":"Lee, J.-H. & Lee, M.-S. Brain iron accumulation in atypical Parkinsonian syndromes: in vivo MRI evidences for distinctive patterns. Front. Neurol. 10, 74 (2019).","journal-title":"Front. Neurol."},{"key":"1544_CR74","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.27100","volume":"32","author":"E Ofori","year":"2017","unstructured":"Ofori, E. et al. Free water improves detection of changes in the substantia nigra in parkinsonism: a multisite study. Mov. Disord. J. Mov. Disord. Soc. 32, 1457\u20131464 (2017).","journal-title":"Mov. Disord. J. Mov. Disord. Soc."},{"key":"1544_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-024-01229-0","volume":"24","author":"M Duan","year":"2024","unstructured":"Duan, M. et al. A rapid multi-parametric quantitative MR imaging method to assess Parkinson\u2019s disease: a feasibility study. BMC Med. Imaging 24, 58 (2024).","journal-title":"BMC Med. Imaging"},{"key":"1544_CR76","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08440","volume":"4","author":"Y Zeighami","year":"2015","unstructured":"Zeighami, Y. et al. Network structure of brain atrophy in de novo Parkinson\u2019s disease. eLife 4, e08440 (2015).","journal-title":"eLife"},{"key":"1544_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02416-0","volume":"9","author":"Y Yau","year":"2018","unstructured":"Yau, Y. et al. Network connectivity determines cortical thinning in early Parkinson\u2019s disease progression. Nat. Commun. 9, 12 (2018).","journal-title":"Nat. Commun."},{"key":"1544_CR78","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroimage.2019.03.001","volume":"192","author":"S Pandya","year":"2019","unstructured":"Pandya, S. et al. Predictive model of spread of Parkinson\u2019s pathology using network diffusion. NeuroImage 192, 178\u2013194 (2019).","journal-title":"NeuroImage"},{"key":"1544_CR79","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1162\/netn_a_00296","volume":"7","author":"A Abdelgawad","year":"2023","unstructured":"Abdelgawad, A. et al. Predicting longitudinal brain atrophy in Parkinson\u2019s disease using a Susceptible-Infected-Removed agent-based model. Netw. Neurosci. 7, 906\u2013925 (2023).","journal-title":"Netw. Neurosci."},{"key":"1544_CR80","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.3390\/jcm11185381","volume":"11","author":"R Zhu","year":"2022","unstructured":"Zhu, R. et al. Total burden of cerebral small vessel disease on MRI may predict cognitive impairment in Parkinson\u2019s disease. J. Clin. Med. 11, 5381 (2022).","journal-title":"J. Clin. Med."},{"key":"1544_CR81","doi-asserted-by":"publisher","first-page":"1156648","DOI":"10.3389\/fnagi.2023.1156648","volume":"15","author":"X Zou","year":"2023","unstructured":"Zou, X. et al. White matter hyperintensities burden in the frontal regions is positively correlated to the freezing of gait in Parkinson\u2019s disease. Front. Aging Neurosci. 15, 1156648 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1544_CR82","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mds.24938","volume":"27","author":"JG Goldman","year":"2012","unstructured":"Goldman, J. G. et al. Entorhinal cortex atrophy differentiates Parkinson\u2019s disease patients with and without dementia. Mov. Disord. J. Mov. Disord. Soc. 27, 727\u2013734 (2012).","journal-title":"Mov. Disord. J. Mov. Disord. Soc."},{"key":"1544_CR83","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1212\/01.WNL.0000153070.82309.D4","volume":"64","author":"CWC Tam","year":"2005","unstructured":"Tam, C. W. C., Burton, E. J., McKeith, I. G., Burn, D. J. & O\u2019Brien, J. T. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64, 861\u2013865 (2005).","journal-title":"Neurology"},{"key":"1544_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41531-021-00164-z","volume":"7","author":"EJ Yoon","year":"2021","unstructured":"Yoon, E. J. & Monchi, O. Probable REM sleep behavior disorder is associated with longitudinal cortical thinning in Parkinson\u2019s disease. Npj Park. Dis. 7, 19 (2021).","journal-title":"Npj Park. Dis."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01544-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:02:49Z","timestamp":1787853769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01544-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01544-z","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}